FUJITA; Mayumi
Patent Applications and Registrations
Patent applications and USPTO patent grants for FUJITA; Mayumi.The latest application filed is for "medical treatment use of cell-membrane-permeable fibroblast growth factor".
- FUJITA; Mayumi - Chiba JP
- Fujita; Mayumi - Englewood CO
- Fujita; Mayumi - Longmont CO
| Patent | Date |
|---|---|
| Medical Treatment Use Of Cell-membrane-permeable Fibroblast Growth Factor App 20150299280 - NAKAYAMA; Fumiaki ; et al. | 2015-10-22 |
| Biomarkers Of Cancer App 20130225437 - Fujita; Mayumi ; et al. | 2013-08-29 |
| Dual Inhibition Of Immunophilin/cyclophilin Family Members And Emmprin Immunoglobulin Receptor Superfamily Members App 20100278829 - Edwards, III; Carl Keith ; et al. | 2010-11-04 |
| Gene Expression Profiling For Identification, Monitoring And Treatment Of Melanoma App 20100248225 - Bankaitis-Davis; Danute M. ; et al. | 2010-09-30 |
| Treatment and Prevention of Skin Injury Due to Exposure to Ultraviolet Light App 20090169497 - Horwitz; Lawrence D. ; et al. | 2009-07-02 |
| NCAGE Code | 48PX1 | FUJITA MAYUMI |
| CAGE Code | 48PX1 | FUJITA, MAYUMI |
| DUNS | 612911037 | FUJITA, MAYUMI |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 